Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
8.89
+0.45 (5.33%)
At close: Apr 15, 2026, 4:00 PM EDT
8.96
+0.07 (0.79%)
After-hours: Apr 15, 2026, 4:16 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $60.29 million as of April 15, 2026. Its market cap has decreased by -48.90% in one year.
Market Cap
60.29M
Enterprise Value
69.34M
1-Year Change
-48.90%
Ranking
Category
Stock Price
$8.89
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $60.29M, a decrease of -97.60%. That is a compound annual growth rate of -52.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 57.24M | -23.27% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 62.21M |
| Dogwood Therapeutics | 59.79M |
| PDS Biotechnology | 59.16M |
| MindWalk Holdings | 58.61M |
| OS Therapies | 58.01M |
| Kezar Life Sciences | 54.25M |
| Aligos Therapeutics | 54.08M |
| Metagenomi Therapeutics | 53.61M |